Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia.

Eun-Ji Choi,Je-Hwan Lee,Jung-Hee Lee,Han-Seung Park,Sun-Hye Ko,Eun-Hye Hur,Juhyun Moon,Bon-Kwan Goo,Yeonhee Kim,Miee Seol,Young-Shin Lee,Young-Ah Kang,Mijin Jeon,Ji Min Woo,Kyoo-Hyung Lee

Leukemia Research（2018）

引用 18|浏览53

暂无评分

摘要

•FLT3-ITD-mutated AML patients benefited from high-dose daunorubicin.•High-dose daunorubicin seems to yield better results than idarubicin.•The results of in vitro studies support these findings.

查看译文

关键词

Acute myeloid leukemia,FLT3-ITD,Induction chemotherapy,Anthracycline

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要